Have a personal or library account? Click to login
The expression of DNAJB9 in normal human astrocytes is more sensitive to nanographene oxide than in glioblastoma cells Cover

The expression of DNAJB9 in normal human astrocytes is more sensitive to nanographene oxide than in glioblastoma cells

Endocrine Regulations
Volume 58 (2024): Issue 1 (January 2024)
By: Oleksandr Minchenko,  Yuliia V. Kulish,  Yuliia M. Viletska,  Olena O. Khita,  Olha V. Rudnytska,  Halyna E. Kozynkevych and  Dmytro O. Minchenko  
Open Access
|Dec 2024
DOI: https://doi.org/10.2478/enr-2024-0029 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Published on: Dec 9, 2024
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
nanographene oxide,
DNAJB9,
DDIT3,
EDEM1,
IDH2,
mRNA expression,
geno-toxicity,
ERN1 knockdown,
normal human astrocytes,
glioblastoma cells
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2024 Oleksandr Minchenko, Yuliia V. Kulish, Yuliia M. Viletska, Olena O. Khita, Olha V. Rudnytska, Halyna E. Kozynkevych, Dmytro O. Minchenko, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 58 (2024): Issue 1 (January 2024)Next article